Association between selective serotonin and serotonin–noradrenaline reuptake inhibitor therapy and hematuria

References

• Jannini TB, Di Lorenzo G, Bianciardi E, et al. Off-label uses of selective serotonin reuptake inhibitors (SSRIs). Curr Neuropharmacol. 2021;19  [published online ahead of print, 2021 May 17].
   Google Scholar
• Heimisdottir AA, Enger E, Morelli S, et al. Use of serotonin reuptake inhibitors is not associated with increased bleeding after CABG. Gen Thorac Cardiovasc Surg. 2020;68(11):1312–1318.
   PubMed Web of Science ®Google Scholar
• Bixby AL, VandenBerg A, Bostwick JR. Clinical management of bleeding risk with antidepressants. Ann Pharmacother. 2019;53(2):186–194.
   PubMed Web of Science ®Google Scholar
• Goethe JW, Woolley SB, Cardoni AA, et al. Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence. J Clin Psychopharmacol. 2007;27(5):451–458.
   PubMed Web of Science ®Google Scholar
• Andrade C, Sandarsh S, Chethan KB, et al. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry. 2010;71(12):1565–1575.
   PubMed Web of Science ®Google Scholar
• Dall M, Schaffalitzky de Muckadell OB, Lassen AT, et al. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2009;7(12):1314–1321.
   PubMed Web of Science ®Google Scholar
• Perrotta C, Giordano F, Colombo A, et al. Postpartum bleeding in pregnant women receiving SSRIs/SNRIs: new insights from a descriptive observational study and an analysis of data from the FAERS database. Clin Ther. 2019;41(9):1755–1766.
   PubMed Web of Science ®Google Scholar
• Jensen MP, Ziff OJ, Banerjee G, et al. The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: a systematic review and Meta-analysis. Eur Stroke J. 2019;4(2):144–152.
   PubMed Web of Science ®Google Scholar
• Barocas DA, Boorjian SA, Alvarez RD, et al. Microhematuria: AUA/SUFU guideline. J Urol. 2020;204(4):778–786.
   PubMed Web of Science ®Google Scholar
• Mariani AJ, Mariani MC, Macchioni C, et al. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989;141(2):350–355.
   PubMed Web of Science ®Google Scholar
• Mohr DN, Offord KP, Owen RA, et al. Asymptomatic microhematuria and urologic disease. a population-based study. JAMA. 1986;256(2):224–229.
   PubMed Web of Science ®Google Scholar
• Cochran KA, Cavallari LH, Shapiro NL, et al. Bleeding incidence with concomitant use of antidepressants and warfarin. Ther Drug Monit. 2011;33(4):433–438.
   PubMed Web of Science ®Google Scholar
• Laporte S, Chapelle C, Caillet P, et al. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies. Pharmacol Res. 2017;118:19–32.
   PubMed Web of Science ®Google Scholar
• Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007;9(1):47–59.
   PubMedGoogle Scholar
• Andrade C, Sharma E. Serotonin reuptake inhibitors and risk of abnormal bleeding. Psychiatr Clin North Am. 2016;39(3):413–426.
   PubMed Web of Science ®Google Scholar
• Verdel BM, Souverein PC, Meenks SD, et al. Use of serotonergic drugs and the risk of bleeding. Clin Pharmacol Ther. 2011;89(1):89–96.
   PubMed Web of Science ®Google Scholar
• Labos C, Dasgupta K, Nedjar H, et al. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ. 2011;183(16):1835–1843.
   PubMed Web of Science ®Google Scholar
• Schellander R, Donnerer J. Antidepressants: clinically relevant drug interactions to be considered. Pharmacology. 2010;86(4):203–215.
   PubMed Web of Science ®Google Scholar
• Löppönen P, Tetri S, Juvela S, et al. Association between warfarin combined with serotonin-modulating antidepressants and increased case fatality in primary intracerebral hemorrhage: a population-based study: clinical article. J Neurosurg. 2014;120(6):1358–1363.
   PubMed Web of Science ®Google Scholar
• Javors MA, Houston JP, Tekell JL, et al. Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int J Neuropsychopharmacol. 2000;3(3):229–235.
   PubMed Web of Science ®Google Scholar
• Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2007;27(1):31–40.
   PubMed Web of Science ®Google Scholar
• Targownik LE, Bolton JM, Metge CJ, et al. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol. 2009;104(6):1475–1482.
   PubMed Web of Science ®Google Scholar
• Naguy A, Abdelhamid HS, Elsori D, et al. Supramaximal dose of ecitalopram-associated hematuria in an adolescent with obsessive-compulsive disorder: a case report. J Clin Psychopharmacol. 2020;40(1):102–103.
   PubMed Web of Science ®Google Scholar
• Singh I, Achuthan S, Chakrabarti A, et al. Influence of pre-operative use of serotonergic antidepressants (SADs) on the risk of bleeding in patients undergoing different surgical interventions: a meta-analysis. Pharmacoepidemiol Drug Saf. 2015;24(3):237–245.
   PubMed Web of Science ®Google Scholar
• Wilson E, Lader M. A review of the management of antidepressant discontinuation symptoms. Ther Adv Psychopharmacol. 2015;5(6):357–368.
   PubMed Web of Science ®Google Scholar
• Maschino F, Hurault-Delarue C, Chebbane L, et al. Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French spontaneous reporting database for a controversial ADR. Eur J Clin Pharmacol. 2012;68(11):1557–1560.
   PubMed Web of Science ®Google Scholar
• Schelleman H, Brensinger CM, Bilker WB, et al. Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study. PLoS One. 2011;6(6):e21447.
   PubMed Web of Science ®Google Scholar
• Samuel NG, Seifert CF. Risk of bleeding in patients on full-dose enoxaparin with venous thromboembolism and selective serotonin reuptake inhibitors. Ann Pharmacother. 2017;51(3):226–231.
   PubMed Web of Science ®Google Scholar
• Oka Y, Okamoto K, Kawashita N, et al. Meta-analysis of the risk of upper gastrointestinal hemorrhage with combination therapy of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs. Biol Pharm Bull. 2014;37(6):947–953.
   PubMed Web of Science ®Google Scholar
• Anglin R, Yuan Y, Moayyedi P, et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109(6):811–819.
   PubMed Web of Science ®Google Scholar
• Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6 Suppl):2473–2481.
   PubMed Web of Science ®Google Scholar
• Tan WS, Sarpong R, Khetrapal P, et al. Can renal and bladder ultrasound replace computerized tomography urogram in patients investigated for microscopic hematuria? J Urol. 2018;200(5):973–980.
   PubMed Web of Science ®Google Scholar
• Loo RK, Lieberman SF, Slezak JM, et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc. 2013;88(2):129–138.
   PubMed Web of Science ®Google Scholar